[ad_1]
Giovanni Caforio, CEO of Bristol-Myers Squibb, told CNBC on Friday that the company "is getting closer to the creation of this excellent company," after the takeover of Celgene by its shareholders.
Source link
[ad_1]
Giovanni Caforio, CEO of Bristol-Myers Squibb, told CNBC on Friday that the company "is getting closer to the creation of this excellent company," after the takeover of Celgene by its shareholders.
Source link